医学診断法ジャーナル
オープンアクセス

概要

Recent Medical Advancements in Diabetic Retinal Disease Treatment

Gloria Simmons

Diabetic retinal disease is a primary cause of preventable blindness and one of the most common consequences of Diabetes Mellitus (DM). Glycemic control, intravitreal, and laser therapy are the mainstays of treatment. Intravitreal therapy, on the other hand, often necessitates repeated hospital visits, and some patients do not see a meaningful improvement in eyesight. Novel and long-acting medicines targeting a variety of pathways are needed, however there is currently inadequate evidence to support appropriate treatment combinations. The discovery of therapeutic medicines that target not just visible microvascular illness and metabolic derangements, but also inflammation and accelerated retinal neurodegeneration is being driven by a better knowledge of the molecular mechanisms involved in pathogenesis. This review outlines existing and emerging treatments for diabetic retinal disorders, as well as providing an outlook on how to manage this critical condition in the future.